Data table |
ID |
COL |
ROW |
NAME |
SPOT_ID |
CONTROL_TYPE |
REFSEQ |
GB_ACC |
LOCUSLINK_ID |
GENE_SYMBOL |
GENE_NAME |
UNIGENE_ID |
ENSEMBL_ID |
TIGR_ID |
ACCESSION_STRING |
CHROMOSOMAL_LOCATION |
CYTOBAND |
DESCRIPTION |
GO_ID |
SEQUENCE |
1 |
96 |
164 |
GE_BrightCorner |
GE_BrightCorner |
pos |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 |
96 |
162 |
DarkCorner |
DarkCorner |
pos |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 |
96 |
160 |
DarkCorner |
DarkCorner |
pos |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 |
96 |
158 |
A_23_P139509 |
A_23_P139509 |
FALSE |
NM_016570 |
NM_016570 |
51290 |
ERGIC2 |
ERGIC and golgi 2 |
Hs.339453 |
ENST00000201023 |
|
ref|NM_016570|ens|ENST00000201023|gb|EU446804|gb|AK222799 |
chr12:29498382-29496163 |
hs|12p11.22 |
Homo sapiens ERGIC and golgi 2 (ERGIC2), mRNA [NM_016570] |
GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005794(Golgi apparatus)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016192(vesicle-mediated transport)|GO:0033116(ER-Golgi intermediate compartment membrane) |
AGAAAGGGAACGTATCATTAACCATGCTGCAGGCAGCCATGGAGTCTCTGGGATATTTAT |
5 |
96 |
156 |
A_23_P211561 |
A_23_P211561 |
FALSE |
NM_152513 |
NM_152513 |
150365 |
MEI1 |
meiosis inhibitor 1 |
Hs.116419 |
ENST00000401548 |
|
ref|NM_152513|ens|ENST00000401548|ens|ENST00000419798|ens|ENST00000400107 |
chr22:42195336-42195395 |
hs|22q13.2 |
Homo sapiens meiosis inhibitor 1 (MEI1), mRNA [NM_152513] |
GO:0005488(binding)|GO:0007126(meiosis) |
AGAATGAGACCTGGAGACAAAGGGCATAATTGTTGGGGAAATGGATGACAGCTGAAGCTA |
6 |
96 |
154 |
A_24_P243776 |
A_24_P243776 |
FALSE |
NM_021994 |
NM_021994 |
11179 |
ZNF277 |
zinc finger protein 277 |
Hs.655904 |
ENST00000361946 |
|
ref|NM_021994|ens|ENST00000361946|ens|ENST00000361822|gb|AF209198 |
chr7:111982790-111982849 |
hs|7q31.1 |
Homo sapiens zinc finger protein 277 (ZNF277), mRNA [NM_021994] |
GO:0003677(DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0008270(zinc ion binding)|GO:0046872(metal ion binding) |
CTTGAAAACCTAGAAGAAACTACCACAGAAGCAATTTTTCATGTTTTTCTCCTATGAGAC |
7 |
96 |
152 |
A_33_P3287745 |
A_33_P3287745 |
FALSE |
NM_182958 |
NM_182958 |
84148 |
KAT8 |
K(lysine) acetyltransferase 8 |
Hs.533803 |
ENST00000448516 |
|
ref|NM_182958|ref|NM_032188|ens|ENST00000448516|ens|ENST00000538768 |
chr16:31142601-31142660 |
hs|16p11.2 |
Homo sapiens K(lysine) acetyltransferase 8 (KAT8), transcript variant 2, mRNA [NM_182958] |
GO:0004402(histone acetyltransferase activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0008134(transcription factor binding)|GO:0016407(acetyltransferase activity)|GO:0016568(chromatin modification)|GO:0016573(histone acetylation)|GO:0030099(myeloid cell differentiation)|GO:0035064(methylated histone residue binding)|GO:0043984(histone H4-K16 acetylation)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0045893(positive regulation of transcription, DNA-dependent)|GO:0046872(metal ion binding)|GO:0071339(MLL1 complex)|GO:0072487(MSL complex) |
GGACCTGAGCCTCCTGGCTCCCAGCCTGTAAATATGTATAGACCTGTTTTGTCATTTTTT |
8 |
96 |
150 |
A_23_P167683 |
A_23_P167683 |
FALSE |
NM_000514 |
NM_000514 |
2668 |
GDNF |
glial cell derived neurotrophic factor |
Hs.248114 |
|
|
ref|NM_000514|ref|NM_001190468|ref|NM_001190469|ref|NM_199231 |
chr5:37816024-37815965 |
hs|5p13.2 |
Homo sapiens glial cell derived neurotrophic factor (GDNF), transcript variant 1, mRNA [NM_000514] |
GO:0001656(metanephros development)|GO:0001657(ureteric bud development)|GO:0001658(branching involved in ureteric bud morphogenesis)|GO:0001755(neural crest cell migration)|GO:0001759(organ induction)|GO:0001941(postsynaptic membrane organization)|GO:0005102(receptor binding)|GO:0005576(extracellular region)|GO:0006916(anti-apoptosis)|GO:0007165(signal transduction)|GO:0007399(nervous system development)|GO:0007411(axon guidance)|GO:0008083(growth factor activity)|GO:0008344(adult locomotory behavior)|GO:0021784(postganglionic parasympathetic nervous system development)|GO:0030432(peristalsis)|GO:0031175(neuron projection development)|GO:0032770(positive regulation of monooxygenase activity)|GO:0033603(positive regulation of dopamine secretion)|GO:0042803(protein homodimerization activity)|GO:0043524(negative regulation of neuron apoptosis)|GO:0045944(positive regulation of transcription from RNA polymerase II promoter)|GO:0048255(mRNA stabilization)|GO:0048484(enteric nervous system development)|GO:0048485(sympathetic nervous system development)|GO:0051584(regulation of dopamine uptake)|GO:0060688(regulation of morphogenesis of a branching structure)|GO:0072107(positive regulation of ureteric bud formation)|GO:0072108(positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis)|GO:0090190(positive regulation of branching involved in ureteric bud morphogenesis) |
CAATACATTTAAATGTCACTGACTTGGGTCTGGGCTATGAAACCAAGGAGGAACTGATTT |
9 |
96 |
148 |
A_24_P363408 |
A_24_P363408 |
FALSE |
NM_012259 |
NM_012259 |
23493 |
HEY2 |
hairy/enhancer-of-split related with YRPW motif 2 |
Hs.144287 |
ENST00000368364 |
|
ref|NM_012259|ens|ENST00000368364|ens|ENST00000368365|gb|AJ249545 |
chr6:126082004-126082063 |
hs|6q22.31 |
Homo sapiens hairy/enhancer-of-split related with YRPW motif 2 (HEY2), mRNA [NM_012259] |
GO:0000122(negative regulation of transcription from RNA polymerase II promoter)|GO:0000983(RNA polymerase II core promoter sequence-specific DNA binding transcription factor activity)|GO:0000988(protein binding transcription factor activity)|GO:0001102(RNA polymerase II activating transcription factor binding)|GO:0001570(vasculogenesis)|GO:0003208(cardiac ventricle morphogenesis)|GO:0003677(DNA binding)|GO:0003700(sequence-specific DNA binding transcription factor activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0006355(regulation of transcription, DNA-dependent)|GO:0007219(Notch signaling pathway)|GO:0007389(pattern specification process)|GO:0008134(transcription factor binding)|GO:0010629(negative regulation of gene expression)|GO:0016580(Sin3 complex)|GO:0017053(transcriptional repressor complex)|GO:0035939(microsatellite binding)|GO:0042826(histone deacetylase binding)|GO:0043565(sequence-specific DNA binding)|GO:0045746(negative regulation of Notch signaling pathway)|GO:0045892(negative regulation of transcription, DNA-dependent)|GO:0051145(smooth muscle cell differentiation)|GO:0055015(ventricular cardiac muscle cell development)|GO:0060045(positive regulation of cardiac muscle cell proliferation)|GO:0060633(negative regulation of transcription initiation from RNA polymerase II promoter)|GO:0090102(cochlea development)|GO:0097084(vascular smooth muscle cell development)|GO:2000678(negative regulation of transcription regulatory region DNA binding) |
AAGCTCTTTGTCAAGTTAGTGATTGCATTTGATCCCAAAACAAGATGAATGTATGCAATG |
10 |
96 |
146 |
A_33_P3229375 |
A_33_P3229375 |
FALSE |
NM_001099780 |
NM_001099780 |
122706 |
PSMB11 |
proteasome (prosome, macropain) subunit, beta type, 11 |
Hs.508918 |
ENST00000408907 |
|
ref|NM_001099780|ens|ENST00000408907|tc|THC2618635 |
chr14:23512952-23513011 |
hs|14q11.2 |
Homo sapiens proteasome (prosome, macropain) subunit, beta type, 11 (PSMB11), mRNA [NM_001099780] |
GO:0000075(cell cycle checkpoint)|GO:0000084(S phase of mitotic cell cycle)|GO:0000209(protein polyubiquitination)|GO:0000216(M/G1 transition of mitotic cell cycle)|GO:0000278(mitotic cell cycle)|GO:0002474(antigen processing and presentation of peptide antigen via MHC class I)|GO:0004298(threonine-type endopeptidase activity)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0005839(proteasome core complex)|GO:0006521(regulation of cellular amino acid metabolic process)|GO:0006915(apoptosis)|GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest)|GO:0008233(peptidase activity)|GO:0016032(viral reproduction)|GO:0016070(RNA metabolic process)|GO:0016071(mRNA metabolic process)|GO:0031145(anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process)|GO:0034641(cellular nitrogen compound metabolic process)|GO:0042981(regulation of apoptosis)|GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle)|GO:0051603(proteolysis involved in cellular protein catabolic process) |
TTTACAGAAGAGGAATCAGGTTCAAAGGGTTATGTGGCTTGCCAGGGTCACACAGTAAGT |
11 |
96 |
144 |
A_23_P57829 |
A_23_P57829 |
FALSE |
NM_153635 |
NM_153635 |
151835 |
CPNE9 |
copine family member IX |
Hs.121335 |
ENST00000383831 |
|
ref|NM_153635|ens|ENST00000383831|ens|ENST00000383832|gb|BC035735 |
chr3:9768395-9768844 |
hs|3p25.3 |
Homo sapiens copine family member IX (CPNE9), mRNA [NM_153635] |
|
CCATGTTTGAGGCAATGGAAGAGTTGGACGGTGATGATGTGCGCGTGTCCTCTAGGGGAC |
12 |
96 |
142 |
A_23_P11685 |
A_23_P11685 |
FALSE |
NM_024420 |
NM_024420 |
5321 |
PLA2G4A |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
Hs.497200 |
ENST00000442353 |
|
ref|NM_024420|ens|ENST00000442353|ens|ENST00000367466|gb|BC114340 |
chr1:186957652-186957711 |
hs|1q31.1 |
Homo sapiens phospholipase A2, group IVA (cytosolic, calcium-dependent) (PLA2G4A), mRNA [NM_024420] |
GO:0001542(ovulation from ovarian follicle)|GO:0001554(luteolysis)|GO:0004622(lysophospholipase activity)|GO:0004623(phospholipase A2 activity)|GO:0005509(calcium ion binding)|GO:0005544(calcium-dependent phospholipid binding)|GO:0005624(membrane fraction)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005783(endoplasmic reticulum)|GO:0005789(endoplasmic reticulum membrane)|GO:0005794(Golgi apparatus)|GO:0005829(cytosol)|GO:0006663(platelet activating factor biosynthetic process)|GO:0006690(icosanoid metabolic process)|GO:0007568(aging)|GO:0007596(blood coagulation)|GO:0008152(metabolic process)|GO:0008284(positive regulation of cell proliferation)|GO:0009395(phospholipid catabolic process)|GO:0009408(response to heat)|GO:0009725(response to hormone stimulus)|GO:0010243(response to organic nitrogen)|GO:0016023(cytoplasmic membrane-bounded vesicle)|GO:0016042(lipid catabolic process)|GO:0016787(hydrolase activity)|GO:0019369(arachidonic acid metabolic process)|GO:0030168(platelet activation)|GO:0030501(positive regulation of bone mineralization)|GO:0031340(positive regulation of vesicle fusion)|GO:0031394(positive regulation of prostaglandin biosynthetic process)|GO:0031622(positive regulation of fever generation)|GO:0032496(response to lipopolysaccharide)|GO:0033280(response to vitamin D)|GO:0042542(response to hydrogen peroxide)|GO:0042588(zymogen granule)|GO:0043065(positive regulation of apoptosis)|GO:0043129(surfactant homeostasis)|GO:0046456(icosanoid biosynthetic process)|GO:0046697(decidualization)|GO:0047498(calcium-dependent phospholipase A2 activity)|GO:0048471(perinuclear region of cytoplasm)|GO:0050482(arachidonic acid secretion)|GO:0050729(positive regulation of inflammatory response)|GO:0051384(response to glucocorticoid stimulus)|GO:0051592(response to calcium ion)|GO:0051597(response to methylmercury)|GO:0071236(cellular response to antibiotic) |
GAAATGGCAGCAGTTTCTGATGCTGAGGCAGTTTGCAATCCCATGACAACTGGATTTAAA |
13 |
96 |
140 |
A_33_P3380652 |
A_33_P3380652 |
FALSE |
NM_021777 |
NM_021777 |
10863 |
ADAM28 |
ADAM metallopeptidase domain 28 |
Hs.174030 |
ENST00000540823 |
|
ref|NM_021777|ens|ENST00000540823|ens|ENST00000437154|ens|ENST00000397649 |
chr8:24193030-24193089 |
hs|8p21.2 |
Homo sapiens ADAM metallopeptidase domain 28 (ADAM28), transcript variant 3, mRNA [NM_021777] |
GO:0004222(metalloendopeptidase activity)|GO:0005576(extracellular region)|GO:0005886(plasma membrane)|GO:0006508(proteolysis)|GO:0007283(spermatogenesis)|GO:0008233(peptidase activity)|GO:0008237(metallopeptidase activity)|GO:0008270(zinc ion binding)|GO:0016021(integral to membrane)|GO:0046872(metal ion binding) |
ATCTGGTAATTGTCCTGATGATAGATTCCAAGTCAATGGCTTCCCTTGCCATCACGGGAA |
14 |
96 |
138 |
A_33_P3274696 |
A_33_P3274696 |
FALSE |
NM_024531 |
NM_024531 |
79581 |
GPR172A |
G protein-coupled receptor 172A |
Hs.6459 |
ENST00000402965 |
|
ref|NM_024531|ens|ENST00000402965|ens|ENST00000530047|ens|ENST00000540505 |
chr8:145584871-145584930 |
hs|8q24.3 |
Homo sapiens G protein-coupled receptor 172A (GPR172A), mRNA [NM_024531] |
GO:0004872(receptor activity)|GO:0005886(plasma membrane)|GO:0005887(integral to plasma membrane)|GO:0006810(transport)|GO:0032217(riboflavin transporter activity)|GO:0032218(riboflavin transport) |
TAGGGTAAGCCCCTGAGCCTGGGACCTACATGTGGTTTGCGTAATAAAACATTTGTATTT |
15 |
96 |
136 |
A_21_P0013318 |
A_21_P0013318 |
FALSE |
NM_001142414 |
NM_001142414 |
|
CRCP |
CGRP receptor component |
Hs.571280 |
|
|
ref|NM_001142414|ref|NM_014478|ref|NM_001040647|ref|NR_024548 |
chr7:65599300-65599359 |
hs|7q11.21 |
Homo sapiens CGRP receptor component (CRCP), transcript variant 4, mRNA [NM_001142414] |
GO:0000166(nucleotide binding)|GO:0001635(calcitonin gene-related polypeptide receptor activity)|GO:0001669(acrosomal vesicle)|GO:0003824(catalytic activity)|GO:0003899(DNA-directed RNA polymerase activity)|GO:0004948(calcitonin receptor activity)|GO:0005634(nucleus)|GO:0005886(plasma membrane)|GO:0006383(transcription from RNA polymerase III promoter)|GO:0006950(response to stress)|GO:0006954(inflammatory response)|GO:0007218(neuropeptide signaling pathway)|GO:0007340(acrosome reaction)|GO:0009360(DNA polymerase III complex)|GO:0009615(response to virus)|GO:0044237(cellular metabolic process)|GO:0045087(innate immune response) |
CACCAGAGTCCTGAGATTGTCAGAGAATTTCTCACAGCAATGAAAAGCCACAAGTTGACC |
16 |
96 |
134 |
A_23_P71148 |
A_23_P71148 |
FALSE |
NM_000712 |
NM_000712 |
644 |
BLVRA |
biliverdin reductase A |
Hs.488143 |
ENST00000265523 |
|
ref|NM_000712|ens|ENST00000265523|ens|ENST00000402924|gb|AK291862 |
chr7:43846842-43846901 |
hs|7p13 |
Homo sapiens biliverdin reductase A (BLVRA), mRNA [NM_000712] |
GO:0000166(nucleotide binding)|GO:0004074(biliverdin reductase activity)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006778(porphyrin metabolic process)|GO:0008270(zinc ion binding)|GO:0016491(oxidoreductase activity)|GO:0042167(heme catabolic process)|GO:0046872(metal ion binding)|GO:0055114(oxidation-reduction process) |
AGGTGATGTAGCACTTCCAAGATGGCACCAGCATTTGGTTCTTCTCAAGAGTTGACCATT |
17 |
96 |
132 |
A_23_P60837 |
A_23_P60837 |
FALSE |
NM_000921 |
NM_000921 |
5139 |
PDE3A |
phosphodiesterase 3A, cGMP-inhibited |
Hs.591150 |
ENST00000359062 |
|
ref|NM_000921|ref|NM_001244683|ens|ENST00000359062|gb|M91667 |
chr12:20833644-20833703 |
hs|12p12.2 |
Homo sapiens phosphodiesterase 3A, cGMP-inhibited (PDE3A), transcript variant 1, mRNA [NM_000921] |
GO:0001556(oocyte maturation)|GO:0004115(3',5'-cyclic-AMP phosphodiesterase activity)|GO:0004119(cGMP-inhibited cyclic-nucleotide phosphodiesterase activity)|GO:0005625(soluble fraction)|GO:0005626(insoluble fraction)|GO:0005829(cytosol)|GO:0006198(cAMP catabolic process)|GO:0006629(lipid metabolic process)|GO:0007165(signal transduction)|GO:0007596(blood coagulation)|GO:0008081(phosphoric diester hydrolase activity)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016787(hydrolase activity)|GO:0019933(cAMP-mediated signaling)|GO:0019934(cGMP-mediated signaling)|GO:0030168(platelet activation)|GO:0030552(cAMP binding)|GO:0040020(regulation of meiosis)|GO:0042493(response to drug)|GO:0043066(negative regulation of apoptosis)|GO:0043116(negative regulation of vascular permeability)|GO:0043117(positive regulation of vascular permeability)|GO:0046872(metal ion binding)|GO:0051591(response to cAMP)|GO:0060282(positive regulation of oocyte development)|GO:0071321(cellular response to cGMP)|GO:0071560(cellular response to transforming growth factor beta stimulus) |
GCTTAGCAAGGAAACAGTGCAGGAAATGTAGGTTACCAACTAAGCAGCTTTTGCTCTTAG |
18 |
96 |
130 |
A_23_P12620 |
A_23_P12620 |
FALSE |
NM_025235 |
NM_025235 |
80351 |
TNKS2 |
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2 |
Hs.329327 |
ENST00000371627 |
|
ref|NM_025235|ens|ENST00000371627|gb|FV253598|gb|AF309033 |
chr10:93624141-93624200 |
hs|10q23.32 |
Homo sapiens tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2 (TNKS2), mRNA [NM_025235] |
GO:0000139(Golgi membrane)|GO:0000209(protein polyubiquitination)|GO:0000242(pericentriolar material)|GO:0000784(nuclear chromosome, telomeric region)|GO:0003950(NAD+ ADP-ribosyltransferase activity)|GO:0005515(protein binding)|GO:0005634(nucleus)|GO:0005635(nuclear envelope)|GO:0005694(chromosome)|GO:0005737(cytoplasm)|GO:0005792(microsome)|GO:0005794(Golgi apparatus)|GO:0006471(protein ADP-ribosylation)|GO:0016020(membrane)|GO:0016055(Wnt receptor signaling pathway)|GO:0016757(transferase activity, transferring glycosyl groups)|GO:0032212(positive regulation of telomere maintenance via telomerase)|GO:0040014(regulation of multicellular organism growth)|GO:0048471(perinuclear region of cytoplasm)|GO:0070198(protein localization to chromosome, telomeric region)|GO:0070213(protein auto-ADP-ribosylation)|GO:0090263(positive regulation of canonical Wnt receptor signaling pathway) |
CATTATGGCTTGGCAATCTCTTTTATTTGTTGACTCTAGCTCCCTTCAAAGTCGAGGAAA |
19 |
96 |
128 |
A_23_P502464 |
A_23_P502464 |
FALSE |
NM_000625 |
NM_000625 |
4843 |
NOS2 |
nitric oxide synthase 2, inducible |
Hs.709191 |
ENST00000313735 |
|
ref|NM_000625|ens|ENST00000313735|ens|ENST00000379105|gb|AF068236 |
chr17:26083921-26083862 |
hs|17q11.2 |
Homo sapiens nitric oxide synthase 2, inducible (NOS2), mRNA [NM_000625] |
GO:0001666(response to hypoxia)|GO:0001912(positive regulation of leukocyte mediated cytotoxicity)|GO:0002227(innate immune response in mucosa)|GO:0004517(nitric-oxide synthase activity)|GO:0005515(protein binding)|GO:0005516(calmodulin binding)|GO:0005622(intracellular)|GO:0005634(nucleus)|GO:0005737(cytoplasm)|GO:0005829(cytosol)|GO:0006527(arginine catabolic process)|GO:0006801(superoxide metabolic process)|GO:0006809(nitric oxide biosynthetic process)|GO:0007596(blood coagulation)|GO:0010181(FMN binding)|GO:0016491(oxidoreductase activity)|GO:0018119(peptidyl-cysteine S-nitrosylation)|GO:0020037(heme binding)|GO:0030168(platelet activation)|GO:0030863(cortical cytoskeleton)|GO:0034617(tetrahydrobiopterin binding)|GO:0034618(arginine binding)|GO:0042127(regulation of cell proliferation)|GO:0042177(negative regulation of protein catabolic process)|GO:0042742(defense response to bacterium)|GO:0042803(protein homodimerization activity)|GO:0043457(regulation of cellular respiration)|GO:0046872(metal ion binding)|GO:0048471(perinuclear region of cytoplasm)|GO:0050660(flavin adenine dinucleotide binding)|GO:0050661(NADP binding)|GO:0050796(regulation of insulin secretion)|GO:0050829(defense response to Gram-negative bacterium)|GO:0051712(positive regulation of killing of cells of other organism)|GO:0071222(cellular response to lipopolysaccharide)|GO:0071346(cellular response to interferon-gamma) |
TGTGTACAGTTATTTATGCCTCTGTATTTAAAAAACTAACACCCAGTCTGTTCCCCATGG |
20 |
96 |
126 |
A_23_P346265 |
A_23_P346265 |
FALSE |
NM_024312 |
NM_024312 |
79158 |
GNPTAB |
N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits |
Hs.46850 |
ENST00000549940 |
|
ref|NM_024312|ens|ENST00000549940|ens|ENST00000299314|gb|BC002779 |
chr12:102190514-102190455 |
hs|12q23.2 |
Homo sapiens N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits (GNPTAB), mRNA [NM_024312] |
GO:0000139(Golgi membrane)|GO:0003976(UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity)|GO:0005634(nucleus)|GO:0005794(Golgi apparatus)|GO:0008134(transcription factor binding)|GO:0009306(protein secretion)|GO:0016020(membrane)|GO:0016021(integral to membrane)|GO:0016772(transferase activity, transferring phosphorus-containing groups)|GO:0030154(cell differentiation)|GO:0046835(carbohydrate phosphorylation)|GO:0046872(metal ion binding) |
ATACCATGTTTTGTTTGATTCCTATAGAGACAATATTGCTGGAAAGTCCTTTCAGAATCG |